MARATTO

article · Scientific Reports

FCGR3A V158F gene polymorphism and trastuzumab response in HER2-positive breast cancer patients

20241 citationOpen accessAin Shams University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • HER2/EGFR in Cancer Research
  • Monoclonal and Polyclonal Antibodies Research
  • Peptidase Inhibition and Analysis

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1038/s41598-024-76024-6

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.